1-17270928-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 8P and 5B. PP5_Very_StrongBP4BS2
The NM_016233.2(PADI3):c.881C>T(p.Ala294Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00756 in 1,614,098 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0062 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0077 ( 55 hom. )
Consequence
PADI3
NM_016233.2 missense
NM_016233.2 missense
Scores
6
5
6
Clinical Significance
Conservation
PhyloP100: 7.38
Genes affected
PADI3 (HGNC:18337): (peptidyl arginine deiminase 3) This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type III enzyme modulates hair structural proteins, such as filaggrin in the hair follicle and trichohyalin in the inner root sheath, during hair follicle formation. Together with the type I enzyme, this enzyme may also play a role in terminal differentiation of the epidermis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PP5
Variant 1-17270928-C-T is Pathogenic according to our data. Variant chr1-17270928-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 374867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-17270928-C-T is described in UniProt as null. Variant chr1-17270928-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.02340281). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI3 | NM_016233.2 | c.881C>T | p.Ala294Val | missense_variant | 8/16 | ENST00000375460.3 | NP_057317.2 | |
PADI3 | XM_011541571.3 | c.767C>T | p.Ala256Val | missense_variant | 8/16 | XP_011539873.1 | ||
PADI3 | XM_017001463.2 | c.344C>T | p.Ala115Val | missense_variant | 5/13 | XP_016856952.1 | ||
PADI3 | XM_011541572.3 | c.881C>T | p.Ala294Val | missense_variant | 8/12 | XP_011539874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI3 | ENST00000375460.3 | c.881C>T | p.Ala294Val | missense_variant | 8/16 | 1 | NM_016233.2 | ENSP00000364609.3 |
Frequencies
GnomAD3 genomes AF: 0.00623 AC: 948AN: 152150Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
948
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00677 AC: 1703AN: 251382Hom.: 15 AF XY: 0.00699 AC XY: 950AN XY: 135866
GnomAD3 exomes
AF:
AC:
1703
AN:
251382
Hom.:
AF XY:
AC XY:
950
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00770 AC: 11256AN: 1461830Hom.: 55 Cov.: 33 AF XY: 0.00771 AC XY: 5607AN XY: 727224
GnomAD4 exome
AF:
AC:
11256
AN:
1461830
Hom.:
Cov.:
33
AF XY:
AC XY:
5607
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00623 AC: 948AN: 152268Hom.: 7 Cov.: 32 AF XY: 0.00622 AC XY: 463AN XY: 74458
GnomAD4 genome
AF:
AC:
948
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
463
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
28
ALSPAC
AF:
AC:
34
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
89
ExAC
AF:
AC:
809
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:11Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:5Benign:1
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2022 | Published functional studies demonstrate a damaging effect; specifically, the A294V variant is associated with decreased enzyme activity and abnormal enzyme aggregation (Basmanav et al., 2016).; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29756256, 22381266, 27866708, 31952341, 34426522, 35279260, 24629392) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | PADI3: PM3:Very Strong, PM2:Supporting - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, flagged submission | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Uncombable hair syndrome 1 Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | OMIM | May 25, 2022 | - - |
Pathogenic, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | NM_016233.2:c.881C>T in the PADI3 gene has an allele frequency of 0.017 in Ashkenazi Jewish subpopulation in the gnomAD database. Functional studies demonstrate that c.881C>T has affected transglutaminase activity of TGM3 produced in HEK293T cells (PMID: 27866708). It was detected in multiple individuals with autosomal recessive Uncombable hair syndrome, homozygous c.881C> T(p.Ala294Val), compound heterozygous with c.335T>A (p.Leu112His) ,c.1732A>T (p.Lys578*)(PMID: 27866708). The patient's phenotype is highly specific for PADI3 gene(PMID: 27866708). Pathogenic computational verdict because pathogenic predictions from DANN, EIGEN, FATHMM-MKL, MutationAssessor, MutationTaster and SIFT. Taken together, we interprete this variant as Pathogenic/Likely pathogenic variant. ACMG/AMP criteria applied: PS3; PM3_Strong; PP4; PP3. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | May 31, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | Sep 24, 2024 | The PADI3 c.881C>T (p.Ala294Val) variant (rs144080386) is cited by previous literature (Basmanav et al. 2016. PubMed ID 27866708). This variant is reported as pathogenic by laboratories in ClinVar (Variation ID: 374867). GnomAD 4.1.0 frequency is 0.007561 with 62 homozygotes. It is an OMIM variant: https://omim.org/entry/606755#0001. Prediction of the impact of the variant on the resulting protein and immunofluorescence studies were performed by Basmanav et al. 2016 with results coherent with modified function. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 14, 2024 | - - |
PADI3-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The PADI3 c.881C>T variant is predicted to result in the amino acid substitution p.Ala294Val. This variant has been reported in both the homozygous and heterozygous states as causative for uncombable hair syndrome in several patients (Basmanav et al. 2016. PubMed ID: 27866708; Drivenes et al. 2022. PubMed ID: 35279260). This variant was observed in a public database with allele frequency up to ~0.90% in European populations and 1.75% in Ashkenazi Jewish populations, respectively; 15 homozygotes of this variant were also reported out of 282,758 alleles. Although this variant is common in the general population, it is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at